Management of oral anticoagulation in patients with atrial fibrillation: newer agents, newer conundrums?

J Intern Med. 2018 Dec;284(6):697-699. doi: 10.1111/joim.12755. Epub 2018 Apr 15.

Authors

M Leggio¹, A Fusco², S D'Emidio², P Severi^{1

2}, M Lombardi², E Caldarone², M Armeni³, D Mereu², M G Bendini⁴, A Mazza⁴

Affiliations

¹ Department of Medicine and Rehabilitation, Cardiac Rehabilitation Operative Unit, San Filippo Neri Hospital - Salus Infirmorum Clinic, Rome, Italy.
² Physical Medicine and Neurorehabilitation Operative Unit, Salus Infirmorum Clinic, Rome, Italy.
³ Department of Research, EDUCAM (C.R.O.M.O.N., S.Os.I, A.I.R.O.P.), Rome, Italy.
⁴ Cardiology Division, Santa Maria della Stella Hospital, Orvieto, Italy.

PMID: 29658167
DOI: 10.1111/joim.12755

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants
Atrial Fibrillation*
Cohort Studies
Dabigatran
Humans
Pyrazoles
Pyridones
Rivaroxaban
Stroke*

Substances

Anticoagulants
Pyrazoles
Pyridones
apixaban
Rivaroxaban
Dabigatran